Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0247 Transporter Info
Gene Name	SLC29A1
Transporter Name	Equilibrative nucleoside transporter 1
Gene ID	2030
UniProt ID	Q99808

Post-Translational Modification of This DT
Overview of SLC29A1 Modification Sites with Functional and Structural Information
Sequence	M T T S H Q P Q D R Y K A V W L I F F M L G L G T L L P W N F F M T A T Q Y F T N R L D M S Q N V S L V T A E L S K D A Q A S A A P A A P L P E R N S L S A I F N N V M T L C A M L P L L L F T Y L N S F L H Q R I P Q S V R I L G S L V A I L L V F L I T A I L V K V Q L D A L P F F V I T M I K I V L I N S F G A I L Q G S L F G L A G L L P A S Y T A P I M S G Q G L A G F F A S V A M I C A I A S G S E L S E S A F G Y F I T A C A V I I L T I I C Y L G L P R L E F Y R Y Y Q Q L K L E G P G E Q E T K L D L I S K G E E P R A G K E E S G V S V S N S Q P T N E S H S I K A I L K N I S V L A F S V C F I F T I T I G M F P A V T V E V K S S I A G S S T W E R Y F I P V S C F L T F N I F D W L G R S L T A V F M W P G K D S R W L P S L V L A R L V F V P L L L L C N I K P R R Y L T V V F E H D A W F I F F M A A F A F S N G Y L A S L C M C F G P K K V K P A E A E T A G A I M A F F L C L G L A L G A V F S F L F R A I V
PTM type	X-N-glycosylation X-O-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	48
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC29A1 Asparagine 48 has the potential to affect its expression or activity.
O-glycosylation
Serine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[2]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	63
Experimental Method	Co-Immunoprecipitation
Detailed Description	O-linked Glycosylation at SLC29A1 Serine 63 has the potential to affect its expression or activity.
Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	254
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Serine 254 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	266
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Serine 266 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[3] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	269
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Serine 269 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC29A1			[3] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	271
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Serine 271 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC29A1			[5] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	273
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Serine 273 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC29A1			[5] , [7]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	279
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Serine 279 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC29A1			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	281
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Serine 281 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	143
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Threonine 143 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	248
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Threonine 248 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[5] , [7]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	276
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC29A1 Threonine 276 has the potential to affect its expression or activity.
Ubiquitination
Alanine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	309
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Alanine 309 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	319
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Alanine 319 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	435
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Alanine 435 has the potential to affect its expression or activity.
Arginine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[16]
Role of PTM	Potential impacts
Modified Residue	Arginine	Modified Location	326
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Arginine 326 has the potential to affect its expression or activity.
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	288
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Asparagine 288 has the potential to affect its expression or activity.
Cystine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Cystine	Modified Location	297
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Cystine 297 has the potential to affect its expression or activity.
Glutamicacid	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	264
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Glutamicacid 264 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	265
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Glutamicacid 265 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[12] , [16]
Role of PTM	Potential impacts
Modified Residue	Glutamicacid	Modified Location	325
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Glutamicacid 325 has the potential to affect its expression or activity.
Glutamine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Glutamine	Modified Location	274
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Glutamine 274 has the potential to affect its expression or activity.
Glycine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Glycine	Modified Location	305
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Glycine 305 has the potential to affect its expression or activity.
Histidine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[13] , [18]
Role of PTM	Potential impacts
Modified Residue	Histidine	Modified Location	280
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Histidine 280 has the potential to affect its expression or activity.
Isoleucine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	282
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Isoleucine 282 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	289
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Isoleucine 289 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	318
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Isoleucine 318 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC29A1			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Isoleucine	Modified Location	329
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Isoleucine 329 has the potential to affect its expression or activity.
Leucine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[14] , [15]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	292
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Leucine 292 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[14] , [16]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	335
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Leucine 335 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[14] , [16]
Role of PTM	Potential impacts
Modified Residue	Leucine	Modified Location	343
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Leucine 343 has the potential to affect its expression or activity.
Lysine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[18] , [19]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	239
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Lysine 239 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	249
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Lysine 249 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[13] , [18]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	255
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Lysine 255 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC29A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	263
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Lysine 263 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC29A1			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	283
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Lysine 283 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC29A1			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	356
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Lysine 356 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC29A1			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Lysine	Modified Location	381
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Lysine 381 has the potential to affect its expression or activity.
Methionine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[14] , [16]
Role of PTM	Potential impacts
Modified Residue	Methionine	Modified Location	306
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Methionine 306 has the potential to affect its expression or activity.
Phenylalanine	6 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[14] , [16]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	298
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Phenylalanine 298 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	328
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Phenylalanine 328 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[13] , [18]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	334
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Phenylalanine 334 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC29A1			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	398
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Phenylalanine 398 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC29A1			[15] , [20]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	399
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Phenylalanine 399 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC29A1			[15] , [20]
Role of PTM	Potential impacts
Modified Residue	Phenylalanine	Modified Location	436
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Phenylalanine 436 has the potential to affect its expression or activity.
Proline	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	275
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Proline 275 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	308
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Proline 308 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC29A1			[12] , [13]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	362
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Proline 362 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC29A1			[12] , [15]
Role of PTM	Potential impacts
Modified Residue	Proline	Modified Location	382
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Proline 382 has the potential to affect its expression or activity.
Serine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[13] , [18]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	281
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Serine 281 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC29A1			[16]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	363
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Serine 363 has the potential to affect its expression or activity.
Tryptophan	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[17] , [18]
Role of PTM	Potential impacts
Modified Residue	Tryptophan	Modified Location	342
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Tryptophan 342 has the potential to affect its expression or activity.
Valine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[12] , [14]
Role of PTM	Potential impacts
Modified Residue	Valine	Modified Location	291
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 Valine 291 has the potential to affect its expression or activity.
Unclear Residue	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC29A1			[20] , [21]
Role of PTM	Potential impacts
Modified Location	460
Experimental Method	Co-Immunoprecipitation
Detailed Description	Ubiquitination at SLC29A1 460 has the potential to affect its expression or activity.

References
1	Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 2009 Apr;27(4):378-86.
2	A Chemoenzymatic Method Based on Easily Accessible Enzymes for Profiling Protein O-GlcNAcylation. Anal Chem. 2020 Jul 21;92(14):9807-9814.
3	Robust, Reproducible, and Economical Phosphopeptide Enrichment Using Calcium Titanate. J Proteome Res. 2019 Mar 1;18(3):1411-1417.
4	Capillary Zone Electrophoresis-Tandem Mass Spectrometry for Large-Scale Phosphoproteomics with the Production of over 11,000 Phosphopeptides from the Colon Carcinoma HCT116 Cell Line. Anal Chem. 2019 Feb 5;91(3):2201-2208.
5	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
6	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
7	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
8	Highly reproducible improved label-free quantitative analysis of cellular phosphoproteome by optimization of LC-MS/MS gradient and analytical column construction. J Proteomics. 2017 Aug 8;165:69-74.
9	Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal. 2010 Jan 12;3(104):ra3.
10	Offline pentafluorophenyl (PFP)-RP prefractionation as an alternative to high-pH RP for comprehensive LC-MS/MS proteomics and phosphoproteomics. Anal Bioanal Chem. 2017 Jul;409(19):4615-4625.
11	Opposite Electron-Transfer Dissociation and Higher-Energy Collisional Dissociation Fragmentation Characteristics of Proteolytic K/R(X)n and (X)nK/R Peptides Provide Benefits for Peptide Sequencing in Proteomics and Phosphoproteomics. J Proteome Res. 2017 Feb 3;16(2):852-861.
12	UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol. 2018 Jul;25(7):631-640.
13	Global site-specific neddylation profiling reveals that NEDDylated cofilin regulates actin dynamics. Nat Struct Mol Biol. 2020 Feb;27(2):210-220.
14	Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes. Cell Syst. 2016 Oct 26;3(4):395-403.e4.
15	Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization. Nature. 2013 Apr 18;496(7445):372-6.
16	Proteomic analysis reveals a FANCA-modulated neddylation pathway involved in CXCR5 membrane targeting and cell mobility. J Cell Sci. 2014 Aug 15;127(Pt 16):3546-54.
17	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
18	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.
19	Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells. Proteomics. 2018 Aug;18(15):e1700388.
20	A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
21	Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence